Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease
Status and phase
Conditions
Treatments
Details and patient eligibility
About
The purpose of this study is to determine the best role for capsule endoscopy in diagnosing Crohn's disease.
Full description
Wireless capsule endoscopy (CE) is a Food and Drug Administration (FDA) approved technology that allows viewing of the entire small-bowel. Capsule endoscopy involves swallowing a pill-sized camera that sends images to a data recorder worn on a vest. Because Crohn's disease (CD) often involves the small bowel, we would like to find out if capsule endoscopy is useful in diagnosing small-bowel Crohn's disease. Current methods for diagnosing small-bowel Crohn's disease include colonoscopy, esophagogastroduodenoscopy (EGD), enteroscopy (ENT), single contrast barium small-bowel follow through (SBFT), and double contrast small-bowel enteroclysis (SBE), but these tests are unable to identify the presence or extent of small-bowel disease in many patients.
Sex
Ages
Volunteers
Inclusion criteria
- English speaking adult patients (>18 years old) with known Crohn's disease
Exclusion criteria
- Severe medical or psychiatric co-morbidities
- Active swallowing problems
- Bowel obstruction
- History of stricture or fistula
- Pregnancy
- Taking aspirin/non-steroidal anti-inflammatory drug (NSAID) or potassium chloride (KCl) within 4 weeks prior to the colonoscopy and anytime after colonoscopy
- Inability to consent
- Exclusion of patients whose colonoscopy was done for reasons other than signs/symptoms suggestive of Crohn's disease
Trial design
Primary purpose
Allocation
Interventional model
Masking
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal